US2010076290A1PendingUtilityA1
Health Monitor
Est. expiryJun 21, 2027(~0.9 yrs left)· nominal 20-yr term from priority
Inventors:Daniel M. BernsteinJared WatkinMartin J. FennellMark Kent SloanMichael R. LoveNamvar KiaieJean-Pierre ColeSteve Scott
A61B 2560/0443A61B 5/0017A61B 5/14532A61B 5/14865A61B 5/1495A61B 2560/0456A61B 5/002A61B 2560/0223A61B 5/4839A61B 2560/045A61B 2560/0276A61B 2560/0475A61B 5/1468
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.
Claims
exact text as granted — not AI-modified1 . An analyte monitoring device, comprising:
a control unit; a memory operatively coupled to the control unit and configured to store a plurality of data associated with a monitored analyte level; and a communication unit operatively coupled to the control unit;
wherein control unit is configured to perform one or more of a prospective analysis or a retrospective analysis on the monitored analyte level or on a blood glucose measurement.
2 . The device of claim 1 further including a strip port operatively coupled to the control unit and configured to receive an in vitro test strip.
3 . The device of claim 2 wherein the blood glucose measurement is determined based on a sample received from the in vitro test strip.
4 . The device of claim 3 wherein the memory is further configured to store the blood glucose measurement based on the sample received from the test strip.
5 . The device of claim 2 wherein the monitored analyte level is received from an analyte sensor.
6 . The device of claim 5 wherein the analyte sensor includes a glucose sensor.
7 . The device of claim 5 wherein the analyte sensor is configured for transcutaneous positioning through a skin layer and includes a portion for fluid contact with an interstitial fluid under the skin layer.
8 . The device of claim 5 wherein the control unit is configured to calibrate the analyte sensor based at least in part on the blood glucose measurement.
9 . The device of claim 1 wherein the communication unit is configured to communicate using one or more of a wired connection, a Universal Serial Bus (USB) cable connection, a serial cable connection, a radio frequency (RF) communication protocol, an infrared communication protocol, a Bluetooth communication protocol, or an 802.11x communication protocol.
10 . The device of claim 1 further including an output component operatively coupled to the control unit to display one or more information related to the monitored analyte level or the blood glucose measurement.
11 . The device of claim 10 wherein the output component includes a display.
12 . The device of claim 11 wherein the display includes one or more of a graphical output, a numerical output, or a text output.
13 . The device of claim 10 wherein the output component includes an audible output.
14 . The device of claim 13 wherein the control unit is configured to generate the audible output when one of the plurality of data associated with the monitored analyte level is received.
15 . The device of claim 10 wherein the control unit is configured to generate the one or more information related to the monitored analyte level or the blood glucose measurement.
16 . The device of claim 1 wherein the stored plurality of data correspond to glucose data of the subject collected over a predetermined time period.
17 . The device of claim 1 wherein signals associated with the monitored analyte level are calibrated based at least in part on the blood glucose measurement.
18 . The device of claim 1 wherein the control unit is configured to perform the retrospective analysis of the received plurality of data related to the monitored analyte level based on the blood glucose measurement.
19 . The device of claim 1 wherein the control unit is configured to perform the prospective analysis of one of the plurality of data related to the monitored analyte level received from the analyte sensor in real time.
20 . The device of claim 1 wherein the control unit is configured to correlate the blood glucose measurement to the plurality of data related to the monitored analyte level.
21 . The device of claim 1 wherein the communication unit is configured to receive data associated with the monitored analyte level from a data transfer module.
22 . The device of claim 21 wherein the data transfer module is detachably coupled to the device.
23 . The device of claim 22 wherein the data transfer module is in signal communication with an analyte sensor.
24 . The device of claim 23 wherein the data transfer module is configured to receive a plurality of time spaced analyte data associated with the monitored analyte level.
25 . The device of claim 21 wherein the data transfer module is removably mated with the device, the data transfer module further configured to receive a plurality of signals related to the monitored analyte level.
26 . The device of claim 25 wherein the data transfer module is mated via a Universal Serial Bus (USB) connection.
27 . The device of claim 26 wherein the data transfer module includes a USB port.
28 . The device of claim 26 including a USB connector to removably mate with the data transfer module.
29 . A modular system for processing analyte information, the system comprising:
a health monitor including:
a housing;
a control unit coupled to the housing;
a memory operatively coupled to the control unit and configured to store a plurality of data associated with a monitored analyte level; and
a communication unit operatively coupled to the control unit; and
a data transfer module removably mateable with the health monitor to provide the plurality of data associated with the monitored analyte level;
wherein the control unit is configured to perform one or more of a prospective analysis or a retrospective analysis on the monitored analyte level or on a blood glucose measurement.
30 . The system of claim 29 wherein the health monitor includes a strip port operatively coupled to the control unit and configured to receive an in vitro test strip.
31 . The system of claim 30 wherein the blood glucose measurement is determined based on a sample received from the in vitro test strip.
32 . The system of claim 29 wherein the monitored analyte level is received from an analyte sensor.
33 . The system of claim 32 wherein the analyte sensor includes a glucose sensor.
34 . The system of claim 32 wherein the analyte sensor is configured for transcutaneous positioning through a skin layer and includes a portion for fluid contact with an interstitial fluid under the skin layer.
35 . The system of claim 29 wherein the data transfer module is physically mated with the housing of the health monitor.
36 . The system of claim 29 wherein the data transfer module is mated via a Universal Serial Bus (USB) connection.
37 . The system of claim 36 wherein the data transfer module includes a USB port.
38 . The system of claim 37 wherein the health monitor includes a USB connector to removably mate with the data transfer module.
39 . The system of claim 29 wherein the data transfer module is in signal communication with an analyte sensor.
40 . The system of claim 29 wherein the communication unit of the health monitor is configured to communicate data using one or more of a wired connection, a Universal Serial Bus (USB) cable connection, a serial cable connection, a radio frequency (RF) communication protocol, an infrared communication protocol, a Bluetooth communication protocol, or an 802.11x communication protocol.
41 . The system of claim 29 further including an output component operatively coupled to the housing of the health monitor to display one or more information related to the monitored analyte level or the blood glucose measurement.
42 . The system of claim 41 wherein the output component includes a display.
43 . The system of claim 42 wherein the display includes one or more of a graphical output, a numerical output, or a text output.
44 . The system of claim 41 wherein the output component includes an audible output.
45 . The system of claim 44 wherein the control unit is configured to generate the audible output when one of the plurality of data associated with the monitored analyte level is received.
46 . The system of claim 29 wherein signals associated with the monitored analyte level are calibrated based at least in part on the blood glucose measurement.
47 . The system of claim 29 wherein the control unit is configured to perform the retrospective analysis of the received plurality of data related to the monitored analyte level based on the blood glucose measurement.
48 . The system of claim 29 wherein the control unit is configured to perform the prospective analysis of one of the plurality of data related to the monitored analyte level received from the analyte sensor in real time.
49 . The system of claim 29 wherein the control unit is configured to correlate the blood glucose measurement to the plurality of data related to the monitored analyte level.Join the waitlist — get patent alerts
Track US2010076290A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.